Viral immunity: Basic mechanisms and therapeutic applications—a Keystone Symposia report-Reference-Cited by-全球学者库

Viral immunity: Basic mechanisms and therapeutic applications—a Keystone Symposia report

Published:2023-01-30 Issue:1 Volume:1521 Page:32-45
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Annals of the New York Academy of Sciences

Author:

Cable Jennifer¹,Balachandran Siddharth²,Daley‐Bauer Lisa P.³,Rustagi Arjun⁴,Antony Ferrin⁵,Frere Justin J.⁶,Strampe Jamie⁷,Kedzierska Katherine⁸,Cannon Judy L.⁹,McGargill Maureen A.¹⁰,Weiskopf Daniela¹¹,Mettelman Robert C.¹⁰,Niessl Julia¹²,Thomas Paul G.¹⁰¹³,Briney Bryan¹⁴,Valkenburg Sophie A.¹⁵,Bloom Jesse D.¹⁶¹⁷,Bjorkman Pamela J.¹⁸,Iketani Sho¹⁹,Rappazzo C. Garrett²⁰,Crooks Chelsea M.²¹,Crofts Kali F.²²,Pöhlmann Stefan²³,Krammer Florian²⁴,Sant Andrea J.²⁵,Nabel Gary J.²⁶,Schultz‐Cherry Stacey²⁷

Affiliation:

1. PhD Science Writer New York New York USA

2. Blood Cell Development and Function Program Fox Chase Cancer Center Philadelphia Pennsylvania USA

3. Department of Microbiology and Immunology, Emory Vaccine Center Emory University School of Medicine Atlanta Georgia USA

4. Division of Infectious Diseases and Geographic Medicine, Department of Medicine Stanford University Stanford California USA

5. Department of Pathobiology, College of Veterinary Medicine Auburn University Auburn Alabama USA

6. East Harlem Health Outreach Partnership; Department of Medical Education; and Department of Microbiology Icahn School of Medicine at Mount Sinai New York New York USA

7. Bioinformatics Program Boston University and National Emerging Infectious Diseases Laboratories Boston Massachusetts USA

8. Department of Microbiology and Immunology University of Melbourne at The Peter Doherty Institute for Infection and Immunity Melbourne Victoria Australia

9. Department of Molecular Genetics and Microbiology University of New Mexico School of Medicine Albuquerque New Mexico USA

10. Department of Immunology St. Jude Children's Research Hospital Memphis Tennessee USA

11. Center for Infectious Disease and Vaccine Research La Jolla Institute for Immunology (LJI) La Jolla California USA

12. Department of Medicine, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden

13. Department of Microbiology, Immunology, and Biochemistry University of Tennessee Health Science Center Memphis Tennessee USA

14. Department of Immunology and Microbiology The Scripps Research Institute La Jolla California USA

15. HKU‐Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong PR China

16. Basic Sciences Division and Howard Hughes Medical Institute, Fred Hutchinson Cancer Research Center Seattle Washington USA

17. Department of Microbiology and Department of Genome Sciences University of Washington Seattle Washington USA

18. Division of Biology and Biological Engineering California Institute of Technology Pasadena California USA

19. Aaron Diamond AIDS Research Center Columbia University Vagelos College of Physicians and Surgeons New York New York USA

20. Adimab LLC Lebanon New Hampshire USA

21. Department of Pathobiological Sciences University of Wisconsin‐Madison Madison Wisconsin USA

22. Department of Microbiology and Immunology Wake Forest School of Medicine Winston‐Salem North Carolina USA

23. Infection Biology Unit, German Primate Center and Faculty of Biology and Psychology, University Medical Center Göttingen Georg‐August‐University Göttingen Göttingen Germany

24. Department of Microbiology Icahn School of Medicine at Mount Sinai New York New York USA

25. Department of Infectious Diseases St. Jude Children's Research Hospital Memphis Tennessee USA

26. Modex Therapeutics Inc. an OPKO Health Company Natick Massachusetts USA

27. Department of Laboratory Medicine and Department of Immunology Yale University School of Medicine New Haven Connecticut USA

Abstract

AbstractViruses infect millions of people each year. Both endemic viruses circulating throughout the population as well as novel epidemic and pandemic viruses pose ongoing threats to global public health. Developing more effective tools to address viruses requires not only in‐depth knowledge of the virus itself but also of our immune system's response to infection. On June 29 to July 2, 2022, researchers met for the Keystone symposium “Viral Immunity: Basic Mechanisms and Therapeutic Applications.” This report presents concise summaries from several of the symposium presenters.

Funder

National Institute of Allergy and Infectious Diseases

National Institutes of Health

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nyas.14960

Reference101 articles.

1. RIPK3 Activates Parallel Pathways of MLKL-Driven Necroptosis and FADD-Mediated Apoptosis to Protect against Influenza A Virus

2. DAI Senses Influenza A Virus Genomic RNA and Activates RIPK3-Dependent Cell Death

3. Influenza Virus Z-RNAs Induce ZBP1-Mediated Necroptosis

4. Necroptosis restricts influenza A virus as a stand-alone cell death mechanism

5. Wu T. T.‐H. Travaglini K. J. Rustagi A. Wu T. T.‐H. Travaglini K. J. Rustagi A. Xu D. Zhang Y. Jang S. K. Gillich A. Dehghannasiri R. Martinez‐Colon G. Beck A. Wilk A. J. Morri M. Trope W. L. Shrager J. B. Quake S. R. Kuo C. S. …Salzman J.(2022).Activated interstitial macrophages are a predominant target of viral takeover and focus of inflammation in COVID‐19 initiation in human lung. bioRxiv 2022.05.10.491266.